Marshall Wace LLP Buys New Shares in Gain Therapeutics, Inc. (NASDAQ:GANX)
Marshall Wace LLP purchased a new position in shares of Gain Therapeutics, Inc. (NASDAQ:GANX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 91,738 shares of the company’s stock, valued at approximately $198,000. Marshall Wace LLP owned about […]
Marshall Wace LLP purchased a new position in shares of Gain Therapeutics, Inc. (NASDAQ:GANX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 91,738 shares of the company’s stock, valued at approximately $198,000. Marshall Wace LLP owned about […]
